Status:
COMPLETED
Reduce Ventricular Pacing in Dual Chamber Implantable Cardioverter Defibrillators Using AutoIntrinsic Conduction Search Study
Lead Sponsor:
Abbott Medical Devices
Conditions:
Arrhythmia
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine if patients implanted with a St. Jude Medical (SJM) implantable cardioverter defibrillator (ICD) will benefit by using AutoIntrinsic Conduction Search (AICS) ...
Eligibility Criteria
Inclusion
- Patient has been implanted with a dual chamber SJM ICD with AICS for 1 month (± 2 weeks).
- At the time of enrollment, patient is paced in the right ventricle (RV) ≤25% of the time as determined by the device diagnostics.
- Patient is medically stable.
Exclusion
- Patient has evidence of atrioventricular (AV) block (first, second or third degree) such that ventricular pacing would be required as part of the patient's routine management
- Patient is unable to comply with the follow-up visits due to geographical, psychological, or any other reasons.
- Patient is younger than 18 years of age.
- Patient is pregnant.
Key Trial Info
Start Date :
July 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2007
Estimated Enrollment :
157 Patients enrolled
Trial Details
Trial ID
NCT00187239
Start Date
July 1 2005
End Date
August 1 2007
Last Update
February 4 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AtlantiCare Regional Medical Center
Pomona, New Jersey, United States